Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Three top executives from Theorem Clinical Research
will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-
April 2.
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, and Pacific Biomarkers (PBI), a premier biomarker laboratory services provider ...
read more
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has today announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma’s engineered ...
read more
MRIGlobal and the University of Maryland School of Medicine today announced an intention to collaborate in the development of clinical specimen repositories, laboratory services for clinical trials, and research opportunities. The work will be ...
read more
JLL Partners (JLL), the middle-market private equity firm, and Royal DSM (Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announced the successful closing of the transaction announced in November 2013 combining DSM ...
read more
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in ...
read more
Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. („Finesse“), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient ...
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced that its High Capacity Manufacturing Facility has been successfully validated for commercial production. $45m (USD) has been invested at...
read more
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced two senior appointments to further strengthen its global biologics ...
read more
Gallus BioPharmaceuticals, LLC (Gallus), a premier
pure-play biologics contract manufacturing organization (CMO) has signed a manufacturing
agreement with Symphogen, A/S (Symphogen), a private biopharmaceutical company developing
recombinant ...
read more
Nikki Schopp, Team Leader, Analytical Laboratory Services, at leading pharmaceutical analytical and bioanalytical contract solutions provider, SGS Life Science Services, is to present at the forthcoming Interphex trade show, being held from 18th to ...
read more
Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, 3.France, announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a ...
read more
Celerion is pleased to announce the expansion of clinical operations to South
Korea. Through partnership with Seoul National University Hospital (SNUH), the new Asian office is located
within the SNUH Clinical Trials Center. This enables Celerion ...
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its first abbreviated new drug application (ANDA) in 2014 to the U.S. Food and Drug Administration (FDA), which brings ...
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has received its first approval from the U.S. Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA). The ...
read more